Add office photos
Employer?
Claim Account for FREE
Merck
4.3
based on 303 Reviews
Video summary
Company Overview
Associated Companies
Company Locations
Working at Merck
Company Summary
Merck is a global biopharmaceutical leader, dedicated to advancing health solutions through innovative medicines and vaccines for serious diseases.
Overall Rating
4.3/5
based on 303 reviews
11% above
industry average
Highly rated for
Work-life balance, Company culture, Job security
Work Policy
Hybrid
79% employees reported
Monday to Friday
50% employees reported
Flexible timing
77% employees reported
Within city
31% employees reported
View detailed work policy
Top Employees Benefits
Health insurance
23 employees reported
Job/Soft skill training
22 employees reported
Office cab/shuttle
11 employees reported
Cafeteria
9 employees reported
View all benefits
About Merck
Founded in1891 (134 yrs old)
India Employee Count1k-5k
Global Employee Count50k-1 Lakh
HeadquartersRahway, New Jersey, US
Office Locations
--
Websitemerck.com
Primary Industry
Other Industries
--
Are you managing Merck's employer brand? To edit company information,
claim this page for free
View in video summary
Merck is a leading global biopharmaceutical company that has been inventing for life for more than a century, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. This site is intended for residents of the United States and its territories.
Mission: To discover, develop and provide innovative products and services that save and improve lives around the world.
Vision: To make a difference in the lives of people globally through our innovative medicines, vaccines, and animal health products. We are committed to being the premier, research-intensive biopharmaceutical company and are dedicated to providing leading innovations and solutions for today and the future.
Managing your company's employer brand?
Claim this Company Page for FREE
Merck Ratings
based on 303 reviews
Overall Rating
4.3/5
How AmbitionBox ratings work?
5
184
4
67
3
21
2
9
1
22
Category Ratings
4.3
Work-life balance
4.1
Company culture
4.1
Job security
4.1
Salary
4.0
Skill development
4.0
Work satisfaction
3.6
Promotions
Merck is rated 4.3 out of 5 stars on AmbitionBox, based on 303 company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Merck
based on 289 reviews
4.5
Rated by 51 Women
Rated 4.5 for Work-life balance and 4.3 for Company culture
4.2
Rated by 238 Men
Rated 4.2 for Work-life balance and 4.1 for Salary
Work Policy at Merck
based on 29 reviews in last 6 months
Hybrid
79%
Work from office
21%
Merck Reviews
Top mentions in Merck Reviews
+ 5 more
Compare Merck with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 4.3/5 based on 303 reviews | 4.0/5 based on 1.4k reviews | 4.0/5 based on 1.8k reviews | 4.1/5 based on 1.8k reviews |
Highly Rated for | Work-life balance Salary Job security | Skill development Work-life balance Salary | Work-life balance Company culture Skill development | Company culture Skill development Work-life balance |
Critically Rated for | No critically rated category | Promotions | Promotions | No critically rated category |
Primary Work Policy | Hybrid 79% employees reported | Hybrid 50% employees reported | Work from office 51% employees reported | Hybrid 70% employees reported |
Rating by Women Employees | 4.5 Good rated by 51 women | 3.8 Good rated by 225 women | 4.0 Good rated by 222 women | 4.1 Good rated by 273 women |
Rating by Men Employees | 4.2 Good rated by 238 men | 4.1 Good rated by 1k men | 4.0 Good rated by 1.4k men | 4.1 Good rated by 1.4k men |
Job security | 4.1 Good | 3.7 Good | 3.4 Average | 3.7 Good |
View more
Merck Salaries
Merck salaries have received with an average score of 4.1 out of 5 by 303 employees.
Senior Analyst
(141 salaries)
Unlock
₹6.2 L/yr - ₹23 L/yr
Analyst
(63 salaries)
Unlock
₹3.5 L/yr - ₹10.5 L/yr
System Engineer
(37 salaries)
Unlock
₹4 L/yr - ₹8.3 L/yr
Senior Systems Engineer
(35 salaries)
Unlock
₹5.9 L/yr - ₹13.8 L/yr
Senior Specialist
(27 salaries)
Unlock
₹9.3 L/yr - ₹25.1 L/yr
Software Engineer
(25 salaries)
Unlock
₹3.5 L/yr - ₹8.9 L/yr
Therapy Manager
(24 salaries)
Unlock
₹5 L/yr - ₹11.5 L/yr
Data Engineer
(21 salaries)
Unlock
₹7.4 L/yr - ₹18 L/yr
Data Analyst
(18 salaries)
Unlock
₹3.8 L/yr - ₹9 L/yr
Senior Software Engineer
(16 salaries)
Unlock
₹6 L/yr - ₹15.3 L/yr
Merck Interview Questions
Interview questions by designation
Top Merck interview questions and answers
Get interview-ready with top interview questions
Merck Jobs
Popular Skills Merck Hires for
Current Openings
Merck News
View all
US pharma giant Merck backs healthcare marketplace HD in Southeast Asia
- US pharma giant Merck Sharp & Dohme (MSD) invests in Southeast Asia healthcare marketplace startup, HD, to enhance its AI technology and marketplace, HDmall.
- HD's platform digitizes the healthcare industry in Southeast Asia, assisting users in finding healthcare providers, services, and facilitating installment payment options.
- HD secures $7.8 million in funding, with support from Merck, SBI Ven Capital, M Venture Partners, FEBE Venture, and Partech Partners.
- The startup's marketplace has over 30,000 SKUs from 2,500+ hospitals, clinics, and pharmaceutical partners, serving 400,000 paying customers.
- HD plans to reach 5,000 providers and 600,000 patients by 2025, with recent funding totaling $18 million for AI tech and marketplace enhancement.
- HD's AI chatbot, Jib AI, manages 60% of customer interactions, allowing healthcare professionals to focus on patient care by handling initial tasks.
- Future AI agent improvements include order processing, checkouts, scheduling, electronic health record checking, and virtual care with expert physicians.
- HD aims to expand partnerships with insurance, pharmaceutical companies, employers, and educational institutions in the next two years.
- Southeast Asia's evolving healthcare landscape drives HD's 'B2C2B strategy' to transition from B2C success to enterprise monetization, aligning with market needs.
- HD's innovative approach addresses challenges in Southeast Asia's healthcare industry post-pandemic, emphasizing clarity, transparency, and ease of comparison for users.
- Empowering individuals to make healthcare choices, HD presents a platform similar to Amazon for healthcare services, aiming to expand to Vietnam and Myanmar.
TechCrunch | 13 Feb, 2025
PayPal, Pfizer, and Merck Stocks Are On Sale
- PayPal, Pfizer, and Merck stocks fell after disappointing investors due to various factors.
- PayPal's revenue increased by 5% YoY to $8.4 billion. However, net income declined by 20% to $1.1 billion.
- Pfizer reported a 25% YoY revenue increase to $17.8 billion, but shareholders are not pleased with the current buyback authorization.
- Merck & Co. experienced a 9.07% stock drop after posting a weak outlook and temporarily pausing shipments of its HPV vaccine.
Baystreet | 5 Feb, 2025
US Stocks Steady After Slide As Trade Worries Ease: Markets Wrap
- US equities were relatively flat with the S&P 500 remaining little changed.
- Traders remained alert for news on the impact of a trade war.
- The markets also kept a close eye on a batch of corporate earnings including Alphabet Inc's.
- The Bloomberg Dollar Spot Index fell 0.4% after a 6-day increase.
- Treasury yields increased across the curve.
- Palantir exceeded analysts' estimates with a full-year revenue forecast. PayPal's growth dipped for card-processing business, but recorded strong earnings.
- PepsiCo fell short of sales targets and predicts slow growth for 2025. Clorox posted better-than-expected results and upbeat guidance for the current year.
- Intel decided to sell its self-driving car division to a San Francisco-based start-up, discontinuing work on autonomous vehicles.
- Merck & Co has stopped exports to China of its Gardasil vaccine. Estée Lauder plans to axe positions in corporate restructuring.
- Apollo Global Management and KKR & Co released earnings forecasts.
Bloomberg Quint | 4 Feb, 2025
Jobs Reports Due for Next Week
- The report contains jobs numbers from the US and Canada along with their featured earnings for the upcoming week.
- Monday will see the announcement of economic data regarding the S&P's final US manufacturing PMI, Construction spending, ISM manufacturing and Auto Sales for January.
- On Tuesday, reports will be published announcing job openings data and factory orders for December in the US, as well as the Canadian international merchandise trade for December.
- Wednesday will bring information about ADP employment, US trade deficit, the S&P final US services PMI and ISM services.
- Thursday will see the release of the US initial jobless claims, US productivity for Q4 along with featured earnings for companies including Amazon.com Inc., Eli Lilly And Co, and AstraZeneca PLC.
- Friday will announce the US employment report for January, wholesale inventories and Consumer sentiment, along with earnings from Southern Copper Corp, Fortive Corporation and Kimco Realty Corporation.
- This week's earnings reports include Palantir Technologies, NXP Semiconductors NV, IDEXX Laboratories, Char Technologies, LithiumBank Resources Corp, and TMX Group Limited for Monday.
- On Tuesday, earnings for Alphabet Inc, Toyota Motor Corporation, and Merck & Co Inc will be announced.
- Wednesday's earnings reports include those of NovoNordisk, Alibaba Group Holding Ltd and Walt Disney Co.
- Thursday's featured earnings reports include BCE Inc., Bombardier Inc., Canada Goose Holdings Inc, Colliers International Group Inc., Constellation Software Inc and Lightspeed Commerce Inc.
- Friday's earnings reports include ARC Resources, CAE Inc. Unlimited and Canopy Growth Corporation.
Baystreet | 1 Feb, 2025
When Should Investors Rotate from the Magnificent 7 To Dividend Growth?
- Investors may need to prepare for rotating out of the magnificent seven stocks (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, Tesla) and consider dividend growth stocks.
- The 10-year U.S. treasury bond yields are approaching 5.0%, indicating a potential asset class rotation.
- Defensive industry stocks such as General Dynamics, Lockheed Martin, and RTX, as well as drug sector stocks like Bristol-Myers, Merck, Pfizer, GSK, and AbbVie, are worth considering.
- ETFs like Schwab's SCHD that offer dividends and growth could also be a viable option.
Baystreet | 8 Jan, 2025
Merck Joins with Chinese Distributor on Weight Loss Pill
- Merck has secured the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma.
- The oral drug has not yet entered human trials, and Merck aims to test it for various diseases.
- This deal strengthens Merck's position in the growing obesity drug market.
- Merck will pay Hansoh $112 million upfront with potential milestone payments and royalties.
Baystreet | 18 Dec, 2024
Merck Slips as Anti-Tumor Drug Okayed
- Merck shares decreased in price on Friday as the European Medicines Agency's Committee for Medicinal Products for Human Use recommended the conditional approval of WELIREG, Merck's anti-tumor drug.
- The drug, belzutifan, is an oral hypoxia-inducible factor-2 alpha (HIF-2a) inhibitor.
- The recommendation includes the use of WELIREG for the treatment of adult patients with von Hippel-Lindau (VHL) disease and advanced clear cell renal cell carcinoma (RCC) that has progressed following previous therapies.
- Merck's final marketing authorization decision for the drug in the European Union is expected in the first quarter of 2025.
Baystreet | 13 Dec, 2024
Warning: The Post-Election Rally May Fade
- The S&P 500 closed down by 2.08%, testing the lower channel of its uptrend.
- Trump's controversial appointments and the Federal Reserve's latest commentary might accelerate the post-election rally's fade.
- Healthcare stocks, particularly Merck, GSK, and Moderna, may continue their sell-off if the government is less supportive of vaccines.
- Traders took profits in the chip sector, leading to lower prices for Broadcom, Micron, AMD, and Intel due to concerns about stretched valuations.
Baystreet | 18 Nov, 2024
Powered by
Merck Subsidiaries
MSD Pharmaceuticals
4.1
• 257 reviews
MSD Animal Health
4.1
• 33 reviews
Report error
Compare Merck with
Novartis
4.1
Sanofi
4.2
Bayer
4.1
Eli Lilly and Company
3.9
Abbott
4.1
Bristol-Myers Squibb
4.0
AstraZeneca
4.1
Hetero
3.9
Viatris
4.2
Micro Labs
3.6
Biological E
4.2
Granules India
3.8
Gland Pharma
3.8
Unichem Laboratories
3.8
Fresenius Kabi
4.2
Piramal Pharma
4.0
Novo Nordisk
4.1
Teva Pharmaceuticals
4.0
Otsuka Pharmaceutical India Private Limited
4.1
Par Pharmaceutical Companies
4.3
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to Merck
Pfizer
Manufacturing, Pharma
4.0
• 1.8k reviews
GlaxoSmithKline Pharmaceuticals
Biotech & Life sciences, Healthcare / Pharma, Manufacturing, Pharma
4.1
• 1.8k reviews
Johnson & Johnson
Manufacturing
4.0
• 1.4k reviews
Sanofi
Biotech & Life sciences, Manufacturing, Analytics & KPO, Pharma
4.2
• 1.2k reviews
Bayer
Agriculture, Chemicals / Agri Inputs, Chemicals, Agro Chemicals
4.1
• 732 reviews
Eli Lilly and Company
Pharma
3.9
• 416 reviews
Abbott
Healthcare / Pharma, Media & Entertainment / Publishing, Pharma
4.1
• 3k reviews
Bristol-Myers Squibb
Biotech & Life sciences, Pharma
4.0
• 128 reviews
AstraZeneca
Biotechnology, Pharma
4.1
• 818 reviews
Hetero
Clinical Research, Healthcare, Pharma
3.9
• 3.2k reviews
Viatris
Manufacturing, Pharma
4.2
• 3.1k reviews
Micro Labs
Clinical Research, Pharma
3.6
• 2.2k reviews
Merck FAQs
When was Merck founded?
Merck was founded in 1891. The company has been operating for 134 years primarily in the Pharma sector.
Where is the Merck headquarters located?
Merck is headquartered in Rahway, New Jersey.
How many employees does Merck have in India?
Merck currently has more than 3,400+ employees in India. Marketing & Communication department appears to have the highest employee count in Merck based on the number of reviews submitted on AmbitionBox.
Does Merck have good work-life balance?
Merck has a work-life balance rating of 4.3 out of 5 based on 300+ employee reviews on AmbitionBox. 83% employees rated Merck 4 or above on work-life balance. This rating reflects the company's efforts to help employees maintain a healthy balance between their personal and professional lives. We encourage you to read Merck work-life balance reviews for more details
Is Merck good for career growth?
Career growth at Merck is rated fairly well, with a promotions and appraisal rating of 3.6. 83% employees rated Merck 4 or above, while 17% employees rated it 3 or below on promotions/appraisal. Though the sentiment is mixed for career growth, majority employees have rated it positively. We recommend reading Merck promotions/appraisals reviews for more detailed insights.
What are the pros of working in Merck?
Working at Merck offers several advantages that make it an appealing place for employees. The company is highly rated for work life balance, company culture and job security, based on 300+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
70 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
